Nabriva Therapeutics Prices Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq futures surge 2% as chip outlook calms AI jitters; inflation data awaited
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Nabriva Therapeutics AG (NBRV) IPO Opens Up 8%
September 18, 2015 11:24 AM EDTToday's IPO for Nabriva Therapeutics AG (NASDAQ: NBRV) opened for trading at $11.39 after pricing 9,000,000 American Depositary Shares (ADSs), representing 900,000 of its common shares, at a public offering price of $10.25 per ADS. The pricing was a smidge below the expected... More
Nabriva Therapeutics AG (NBRV) IPO Prices at $10.25/ADS, Slightly Below Expectations
September 18, 2015 8:46 AM EDTNabriva Therapeutics AG (NASDAQ: NBRV) announced he pricing of its initial public offering of 9,000,000 American Depositary Shares (ADSs), representing 900,000 of its common shares, at a public offering price of $10.25 per ADS. The pricing was a smidge below the expected $10.50/ADS. Shares are... More
